ArticlePharmaceutics2023

Dual-Targeted Therapy in HER2-Overexpressing Breast Cancer with Trastuzumab and Novel Cholesterol-Based Nioplexes Silencing Mcl-1.

Supusson Pengnam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.